Replies to post #448987 on Anavex Life Sciences Corp (AVXL)

[Anshu2]

They are hiding it since it failed statistical significance. It’s just too obvious (especially after September PR).

Regarding AUC, Avatar’s endpoint was changed last minute from RSBQ-delta to RSBQ-AUC-delta .. with a very elaborate presentation and justification.

Eventually — CM decided to go back to RSBQ in Excellence with the reason being “there is no need to do AUC, because the larger trial should have sufficient statistical power” —- you can find his exact words on one of the earnings CC, when the analyst was stunned that he was switching back. (I was too).